These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 17207657

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma.
    Kunkel M, Reichert TE, Benz P, Lehr HA, Jeong JH, Wieand S, Bartenstein P, Wagner W, Whiteside TL.
    Cancer; 2003 Feb 15; 97(4):1015-24. PubMed ID: 12569601
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of p63 is associated with radiation resistance and prognosis in oral squamous cell carcinoma.
    Moergel M, Abt E, Stockinger M, Kunkel M.
    Oral Oncol; 2010 Sep 15; 46(9):667-71. PubMed ID: 20656547
    [Abstract] [Full Text] [Related]

  • 4. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
    Eckert AW, Lautner MH, Schütze A, Taubert H, Schubert J, Bilkenroth U.
    Histopathology; 2011 Jun 15; 58(7):1136-47. PubMed ID: 21438910
    [Abstract] [Full Text] [Related]

  • 5. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.
    Lin CY, Hung HC, Kuo RC, Chiang CP, Kuo MY.
    Oral Oncol; 2005 Jul 15; 41(6):645-54. PubMed ID: 15927524
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression of Glut-1 is a prognostic marker for oral squamous cell carcinoma patients.
    Eckert AW, Lautner MH, Taubert H, Schubert J, Bilkenroth U.
    Oncol Rep; 2008 Dec 15; 20(6):1381-5. PubMed ID: 19020718
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression of RCAS1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Tsai TC, Yu CH, Cheng SJ, Liu BY, Chen HM, Chiang CP.
    Oral Oncol; 2008 Aug 15; 44(8):759-66. PubMed ID: 18061525
    [Abstract] [Full Text] [Related]

  • 10. High expression of Jun activation domain-binding protein 1 (Jab1) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation.
    Harada K, Kawashima Y, Yoshida H, Sato M.
    Anticancer Res; 2006 Aug 15; 26(2B):1615-9. PubMed ID: 16619581
    [Abstract] [Full Text] [Related]

  • 11. GLUT-1(+)/TKTL1(+) coexpression predicts poor outcome in oral squamous cell carcinoma.
    Grimm M, Munz A, Teriete P, Nadtotschi T, Reinert S.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun 15; 117(6):743-53. PubMed ID: 24703406
    [Abstract] [Full Text] [Related]

  • 12. Clinicopathological significance of carbonic anhydrase 9, glucose transporter-1, Ki-67 and p53 expression in oral squamous cell carcinoma.
    Kondo Y, Yoshikawa K, Omura Y, Shinohara A, Kazaoka Y, Sano J, Mizuno Y, Yokoi T, Yamada S.
    Oncol Rep; 2011 May 15; 25(5):1227-33. PubMed ID: 21399882
    [Abstract] [Full Text] [Related]

  • 13. Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.
    Kato H, Takita J, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H.
    Anticancer Res; 2002 May 15; 22(5):2635-9. PubMed ID: 12529975
    [Abstract] [Full Text] [Related]

  • 14. FAP-1 and NF-κB expressions in oral squamous cell carcinoma as potential markers for chemo-radio sensitivity and prognosis.
    Nariai Y, Mishima K, Yoshimura Y, Sekine J.
    Int J Oral Maxillofac Surg; 2011 Apr 15; 40(4):419-26. PubMed ID: 21176871
    [Abstract] [Full Text] [Related]

  • 15. High expression of S-phase kinase-associated protein 2 (Skp2) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation.
    Harada K, Supriatno, Kawaguchi S, Kawashima Y, Itashiki Y, Yoshida H, Sato M.
    Anticancer Res; 2005 Apr 15; 25(3c):2471-5. PubMed ID: 16080478
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prognostic implications of glucose transporter protein-1 (glut-1) overexpression in bone and soft-tissue sarcomas.
    Endo M, Tateishi U, Seki K, Yamaguchi U, Nakatani F, Kawai A, Chuman H, Beppu Y.
    Jpn J Clin Oncol; 2007 Dec 15; 37(12):955-60. PubMed ID: 18211986
    [Abstract] [Full Text] [Related]

  • 19. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J.
    Magy Onkol; 2009 Mar 15; 53(1):51-9. PubMed ID: 19318327
    [Abstract] [Full Text] [Related]

  • 20. Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients.
    Eich HT, Löschcke M, Scheer M, Kocher M, Bongartz R, Wacker S, Zöller JE, Müller RP.
    Strahlenther Onkol; 2008 Jan 15; 184(1):23-9. PubMed ID: 18188519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.